4D Molecular Therapeutics
FDMT
FDMT
100 hedge funds and large institutions have $745M invested in 4D Molecular Therapeutics in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 19 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
6% more funds holding
Funds holding: 94 → 100 (+6)
31% less call options, than puts
Call options by funds: $1.3M | Put options by funds: $1.89M
Holders
100
Holding in Top 10
1
Calls
$1.3M
Puts
$1.89M
Top Buyers
| 1 | +$55.5M | |
| 2 | +$54.2M | |
| 3 | +$17.4M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$15.4M |
| 5 |
DM
Deerfield Management
New York
|
+$11.7M |
Top Sellers
| 1 | -$8.59M | |
| 2 | -$5.05M | |
| 3 | -$4.52M | |
| 4 |
Morgan Stanley
New York
|
-$3.15M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$2.5M |